Reducing cardiovascular medication complexity in a german university hospital: Effects of a structured pharmaceutical management intervention on adherence

Journal of Managed Care Pharmacy

Volumn 19, Issue 5, 2013, Pages 396-407

  Stange, Dorit ^a   Kriston, Levente ^a   von Wolff, Alessa ^a   Baehr, Michael ^a   Dartsch, Dorothee C ^b  

^a UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^b CaP Campus Pharmazie GmbH ^*  (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; CARDIOVASCULAR AGENT;

ADULT; ARTICLE; CLINICAL ASSESSMENT TOOL; CONTROLLED STUDY; COUNSELING; DIABETES MELLITUS; DRUG USE; DYSLIPIDEMIA; EVALUATION; FEMALE; GERMANY; HEALTH CARE PERSONNEL; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITAL PHYSICIAN; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MEDICAL STAFF; MEDICATION ADHERENCE RATING SCALE; MEDICATION REGIMEN COMPLEXITY INDEX; PATIENT COMPLIANCE; PATIENT EDUCATION; PATIENT SATISFACTION; PHARMACIST; PROSPECTIVE STUDY; QUALITY OF LIFE; UNIVERSITY HOSPITAL;

EID: 84878983373     PISSN: 10834087     EISSN: None     Source Type: Journal    
DOI: 10.18553/jmcp.2013.19.5.396     Document Type: Article

References (60)

1. Avorn J. Medication use in older patients: better policy could encourage better practice. JAMA. 2010;304(14):1606-07.
2. Sabate E. Adherence to long-term therapies: evidence for action. World Health Organization. 2003. Available at: http://whqlibdoc.who.int/publications/2003/9241545992.pdf. Accessed April 14, 2013.
3. Krousel-Wood M, Thomas S, Muntner P, Morisky D. Medication adherence: a key factor in achieving blood pressure control and good clinical outcomes in hypertensive patients. Curr Opin Cardiol. 2004;19(4):357-62.
4. De Geest S, Sabate E. Adherence to long-term therapies: evidence for action. Eur J Cardiovasc Nurs. 2003;2(4):323.
5. Yeaw J, Benner JS, Walt JG, Sian S, Smith DB. Comparing adherence and persistence across 6 chronic medication classes. J Manag Care Pharm. 2009;15(9):728-40. Available at: http://www.amcp.org/WorkArea/DownloadAsset.aspx?id=8250.
6. Rodgers PT, Ruffin DM. Medication nonadherence-Part I: The health and humanistic consequences. Manag Care Interface. 1998;11(8):58-60.
7. Senst BL, Achusim LE, Genest RP, et al. Practical approach to determining costs and frequency of adverse drug events in a health care network. Am J Health Syst Pharm. 2001;58(12):1126-32.
8. Thinking outside the pillbox: a system-wide approach to improving patient medication adherence for chronic diseases. New England Healthcare Institute (NEHI). August 12, 2009. Available at: http://www.nehi.net/publications/44/thinking_outside_the_pillbox_a_systemwide_approach_to_ improving_patient_medication_adherence_for_chronic_disease. Accessed April 14, 2012.
9. Sullivan SD, Kreling DH, Hazlet TK. Noncompliance with medication regimens and subsequent hospitalizations: a literature analysis and cost of hospitalization estimate. J Res Pharm Econ. 1990;2:19-33.
10. Rodriguez-Monguio R, Otero MJ, Rovira J. Assessing the economic impact of adverse drug effects. Pharmacoeconomics. 2003;21(9):623-50.
11. Wu PH, Yang CY, Yao ZL, Lin WZ, Wu LW, Chang CC. Relationship of blood pressure control and hospitalization risk to medication adherence among patients with hypertension in Taiwan. Am J Hypertens. 2010;23(2):155-60.
12. Simpson SH, Eurich DT, Majumdar SR, et al. A meta-analysis of the association between adherence to drug therapy and mortality. BMJ. 2006;333(7557):15.
13. Burnier M. Medication adherence and persistence as the cornerstone of effective antihypertensive therapy. Am J Hypertens. 2006;19(11):1190-96.
14. Kenna LA, Labbe L, Barrett JS, Pfister M. Modeling and simulation of adherence: approaches and applications in therapeutics. AAPS J. 2005;7(2):E390-E407.
15. Erdine S. Compliance with the treatment of hypertension: the potential of combination therapy. J Clin Hypertens (Greenwich). 2010;12(1):40-46.
16. Mahler C, Hermann K, Horne R, et al. Assessing reported adherence to pharmacological treatment recommendations. Translation and evaluation of the Medication Adherence Report Scale (MARS) in Germany. J Eval Clin Pract. 2010;16(3):574-79.
17. Foddy W. Constructing Questions for Interviews and Questionnaires: Theory and Practice in Social Research. Cambridge: Cambridge University Press; 1993.
18. Simons LA, Ortiz M, Calcino G. Persistence with a single pill versus two pills of amlodipine and atorvastatin: the Australian experience, 2006-2010. Med J Aust. 2011;195(3):134-37.
19. Girvin B, McDermott BJ, Johnston GD. A comparison of enalapril 20 mg once daily versus 10 mg twice daily in terms of blood pressure lowering and patient compliance. J Hypertens. 1999;17(11):1627-31.
20. Donnan PT, MacDonald TM, Morris AD. Adherence to prescribed oral hypoglycaemic medication in a population of patients with Type 2 diabetes: a retrospective cohort study. Diabet Med. 2002;19(4):279-84.
21. Eisen SA, Miller DK, Woodward RS, Spitznagel E, Przybeck TR. The effect of prescribed daily dose frequency on patient medication compliance. Arch Intern Med. 1990;150(9):1881-84.
22. Coleman CI, Limone B, Sobieraj DM, et al. Dosing frequency and medication adherence in chronic disease. J Manag Care Pharm. 2012;18(7):527- 39. Available at: http://www.amcp.org/WorkArea/DownloadAsset. aspx?id=15582.
23. Muir AJ, Sanders LL, Wilkinson WE, Schmader K. Reducing medication regimen complexity: a controlled trial. J Gen Intern Med. 2001;16(2):77-82.
24. DiIorio C, Yeager K, Shafer PO, et al. The epilepsy medication and treatment complexity index: reliability and validity testing. J Neurosci Nurs. 2003;35(3):155-62.
25. George J, Phun YT, Bailey MJ, Kong DC, Stewart K. Development and validation of the medication regimen complexity index. Ann Pharmacother. 2004;38(9):1369-76.
26. Stange D, Kriston L, Langebrake C, et al. Development and psychometric evaluation of the German version of the Medication Regimen Complexity Index (MRCI-D). J Eval Clin Pract. 2012;18(3):515-22.
27. Melchiors AC, Correr CJ, Fernández-Llimos F. Translation and validation into Portuguese language of the medication regimen complexity index. Arq Bras Cardiol. 2007;89(4):210-18.
28. Olmos R, Garcia O, Velasco J, de la Rubia A. Prevalence of polypharmacy in older hospitalised patients. Eur J Hosp Pharm. 2012;19(2):242-43.
29. Stange D, Kriston L, von Wolff A, Baehr M, Dartsch DC. Medication complexity, prescription behaviour and patient adherence at the interface between ambulatory and stationary medical care. Eur J Clin Pharmacol. 2013;69(3):573-80.
30. Himmel W, Tabache M, Kochen MM. What happens to long-term medication when general practice patients are referred to hospital? Eur J Clin Pharmacol. 1996;50(4):253-57.
31. Himmel W, Kochen MM, Sorns U, Hummers-Pradier E. Drug changes at the interface between primary and secondary care. Int J Clin Pharmacol Ther. 2004;42(2):103-09.
32. Viktil KK, Blix HS, Eek AK, Davies MN, Moger TA, Reikvam A. How are drug regimen changes during hospitalisation handled after discharge: a cohort study. BMJ Open. 2012;2(6).
33. Grimmsmann T, Schwabe U, Himmel W. The influence of hospitalisation on drug prescription in primary care-a large-scale follow-up study. Eur J Clin Pharmacol. 2007;63(8):783-90.
34. Mansur N, Weiss A, Hoffman A, Gruenewald T, Beloosesky Y. Continuity and adherence to long-term drug treatment by geriatric patients after hospital discharge: a prospective cohort study. Drugs Aging. 2008;25(10):861-70.
35. Mansur N, Weiss A, Beloosesky Y. Relationship of in-hospital medication modifications of elderly patients to postdischarge medications, adherence, and mortality. Ann Pharmacother. 2008;42(6):783-89.
36. Côté I, Farris K, Feeny D. Is adherence to drug treatment correlated with health-related quality of life? Qual Life Res. 2003;12(6):621-33.
37. Horne R, Hankins M, Jenkins R. The Satisfaction with Information about Medicines Scale (SIMS): a new measurement tool for audit and research. Qual Health Care. 2001;10(3):135-40.
38. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47(6):555-67.
39. George J, Kong DC, Thoman R, Stewart K. Factors associated with medication nonadherence in patients with COPD. Chest. 2005;128(5):3198-204.
40. Correr CJ, Melchiors AC, Fernandez-Llimos F, Pontarolo R. Effects of a pharmacotherapy follow-up in community pharmacies on type 2 diabetes patients in Brazil. Int J Clin Pharm. 2011;33(2):273-80.
41. Jenkinson C, Layte R. Development and testing of the UK SF-12 (short form health survey). J Health Serv Res Policy. 1997;2(1):14-18.
42. Mahler C, Jank S, Hermann K, et al. Psychometric properties of a German version of the "Satisfaction with Information about Medicines Scale" (SIMS-D). Value Health. 2009;12(8):1176-79.
43. Barber N. Ensuring patients' satisfaction with information about their medicines. Qual Health Care. 2001;10(3):130-31.
44. D'Agostino RB, Jr. Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med. 1998;17(19):2265-81.
45. Rosenbaum P, Rubin DB. The central role of the propensity score in observational studies for causal effects. Biometrika. 1983;70(1):41-55. Available at: http://www.jstor.org/discover/10.2307/2335942?uid=3739552&uid=2&uid=4&uid=3739256&sid=21102036048451 . Accessed April 14, 2013.
46. Elliott RA, O'Callaghan CJ. Impact of hospitalisation on the complexity of older patients' medication regimens and potential for regimen simplification. J Pharm Pract Res. 2011;41(1):21-25.
47. Elliott RA. Reducing medication regimen complexity for older patients prior to discharge from hospital: feasibility and barriers. J Clin Pharm Ther. 2012;37(6):637-42.
48. Claxton AJ, Cramer J, Pierce C. A systematic review of the associations between dose regimens and medication compliance. Clin Ther. 2001;23(8):1296-310.
49. Baser O, Andrews LM, Wang L, Xie L. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy. J Med Econ. 2011;14(5):576-83.
50. Carow F, Rieger K, Walter-Sack I, et al. Objective assessment of nonadherence and unknown co-medication in hospitalized patients. Eur J Clin Pharmacol. 2012;68(8):1191-99.
51. Thiebaud P, Patel BV, Nichol MB, Berenbeim DM. The effect of switching on compliance and persistence: the case of statin treatment. Am J Manag Care. Nov 2005;11(11):670-74.
52. Van Wijk BL, Klungel OH, Heerdink ER, de Boer A. The association between compliance with antihypertensive drugs and modification of antihypertensive drug regimen. J Hypertens. 2004;22(9):1831-37.
53. Williams EI, Fitton F. General practitioner response to elderly patients discharged from hospital. BMJ. 1990;300(6718):159-61.
54. Podolsky SH, Greene JA. Combination drugs-hype, harm, and hope. N Engl J Med. 2011;365(6):488-91.
55. Cardone KE, Manley HJ, Grabe DW, Meola S, Hoy CD, Bailie GR. Quantifying home medication regimen changes and quality of life in patients receiving nocturnal home hemodialysis. Hemodial Int. 2011;15(2):234-42.
56. Chiu YW, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R. Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol. 2009;4(6):1089-96.
57. Garber MC, Nau DP, Erickson SR, Aikens JE, Lawrence JB. The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care. 2004;42(7):649-52.
58. van de Steeg N, Sielk M, Pentzek M, Bakx C, Altiner A. Drug-adherence questionnaires not valid for patients taking blood-pressure-lowering drugs in a primary health care setting. J Eval Clin Pract. 2009;15(3):468-72.
59. Fahey T, Montgomery AA, Barnes J, Protheroe J. Quality of care for elderly residents in nursing homes and elderly people living at home: controlled observational study. BMJ. 2003;326(7389):580.
60. Hajjar ER, Hanlon JT, Sloane RJ, et al. Unnecessary drug use in frail older people at hospital discharge. J Am Geriatr Soc. 2005;53(9):1518-23.